Prediction Markets Now Expect AI Start-Up Anthropic to Unseat SpaceX as the Largest IPO in 2026

SpaceX raised $85.7B at its IPO (including underwriters’ overallotment) and initially priced at $135/share on ~555.6M shares, valuing it at $1.77T. Prediction markets (Polymarket/Kalshi) assign a 63% chance that Anthropic will surpass SpaceX as 2026’s largest IPO, with Anthropic’s sales run-rate reportedly jumping from ~$9B (end-2025) to ~$65B (end-July). Despite strong momentum, the article flags valuation and “hot IPO” history risks, citing ~54–55% average year-one drawdowns for the hottest tech IPOs.

Analysis

This is less a fundamentals story than a liquidity/regime signal: capital is still paying the highest prices for opaque, narrative-heavy growth, which tends to help the few liquid public beneficiaries of AI spend more than the private name itself. In the next 1-3 months, the cleaner expression is not chasing a headline IPO but owning the monetizers of AI demand — MSFT, AMZN, GOOGL, and NVDA — because every new mega-valuation keeps enterprise spend and infrastructure budgets politically easier to defend. The caveat is that this only works if the spend translates into durable bookings and gross profit, not just a richer private mark.

For the speculative IPO complex, the market usually gets a first-week euphoria spike followed by a supply overhang as secondary supply, analyst scrutiny, and employee monetization hit. If a $2T-ish private-market print becomes the new reference point, expect public software multiples to get a little more fragile at the margin because investors will demand faster revenue conversion to justify similar growth rates. The immediate reversal risk is simple: a weak first filing, soft lockup demand, or any evidence that ARR is decelerating faster than headline run-rate sales imply.

The contrarian point is that the consensus is treating “bubble” and “no trade” as synonyms. That’s too neat: in liquid public markets, the better trade is often to fade the most sentiment-sensitive vehicle while staying long the companies actually selling the picks and shovels. The structural risk over 6-18 months is that AI adoption disappoints on productivity monetization, at which point even the quality names de-rate — but that is a later-stage thesis, not an immediate reason to short the ecosystem wholesale.

Key Decisions for Investors

• Tactically short SPCX on strength for a 1-3 month mean-reversion trade; keep size modest because post-IPO liquidity and borrow conditions can dominate fundamentals. Falsify the short if price holds above the post-debut high for several sessions or if secondary demand meaningfully tightens.
• Pair trade: long MSFT or AMZN vs. short SPCX / speculative-IPO exposure, targeting 5-10% relative outperformance over 1-3 months if AI-capex enthusiasm spills into the public comps but the IPO trades as a sentiment vehicle.
• Maintain or add to NVDA only on pullbacks, not into euphoric IPO headlines; the best-case linkage is continued capex growth, but the thesis breaks if cloud providers guide down capex growth for two consecutive quarters.
• Set an alert on Anthropic pricing/filing terms: if ARR growth slows or the implied valuation settles materially below the rumored range, expect the broader AI-beta trade to fade and rotate away from high-multiple software.
• If you want a cleaner basket expression, use QQQ/XLK as the long leg and a speculative-IPO short as the hedge rather than betting against mega-cap tech outright.